EU Urged To Probe Gilead, Novartis, Roche, Aspen Pricing
European and Italian consumer organizations Wednesday urged the European Commission to investigate whether Gilead, Novartis, Roche and Aspen, four drug companies that Italy and the U.S. have accused of anticompetitive practices,...To view the full article, register now.
Already a subscriber? Click here to view full article